Ipecac Side Effects

Please note - some side effects for Ipecac may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

Side Effects of Ipecac - for the Consumer

Ipecac Syrup

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Ipecac Syrup:

Diarrhea; drowsiness; stomach cramps; vomiting.

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); continued vomiting; fast or irregular heartbeat.

Side Effects by Body System

General

Chronic ipecac abuse has occurred, particularly in patients with eating disorders (anorexia or bulemia). Chronic diarrhea, vomiting, colitis, muscle weakness, lethargy, hypothermia, impaired peripheral vascular circulation, elevated plasma CPK concentrations, cardiomyopathy, fever, hepatic and renal dysfunction, dental abnormalities, and interstitial edema have been reported.

Cardiovascular

Each 30 mL of ipecac contains approximately 21 mg of emetine. An acute lethal dose is estimated to be less than or equal to 20 mg/kg of emetine. Emetine is slowly eliminated by the kidney (detectable in the urine 40 to 60 days after short term amebicide therapy) and accumulation occurs with chronic use.

Cardiovascular side effects have included tachycardia, palpitations, prolonged QT and PR intervals, inverted T waves, ST segment abnormalities, decreased cardiac output, and hypotension. Vascular accidents or hemorrhage due to emesis-induced blood pressure increases have occurred in patients with cardiovascular dysfunction. Accumulation of the emetine alkaloid during chronic ingestion has resulted in toxic myopathy. Fatalities have occurred.

Musculoskeletal

Musculoskeletal side effects have included skeletal muscle toxicity due to emetine accumulation with chronic dosing. Reversible myopathy with symptoms of weakness and stiffness has occurred.

Gastrointestinal

Gastrointestinal side effects have included protracted vomiting (< 5%), diarrhea (16% to 26% in one case series), anorexia, and esophagitis. Esophageal Mallory-Weiss tears, strictures and ulcerations have also been reported.

Nervous system

Nervous system side effects have included drowsiness (20%), lethargy, and irritability.

Metabolic

Metabolic alterations such as electrolyte imbalance and dehydration have occurred with repeat vomiting during acute therapy and with chronic administration.

Respiratory

Respiratory effects occurring during emesis have included aspiration pneumonitis, pneumomediastinum, and retropneumoperitoneum.

Dermatologic

Dermatologic side effects have included rash or dry skin during chronic use of ipecac.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.